Protective effect of tetraethyl pyrazine against focal cerebral ischemia/reperfusion injury in rats: Therapeutic time window and its mechanism

Thrombosis Research

Volumn 123, Issue 5, 2009, Pages 727-730

  Jia, Jie ^a   Zhang, Xi ^b   Hu, Yong Shan ^a   Wu, Yi ^a   Wang, Qing Zhi ^b   Li, Na Na ^b   Wu, Cai Qin ^b   Yu, Hui Xian ^a   Guo, Qing Chuan ^b  

^a FUDAN UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

focal cerebral; Ischemia reperfusion; tetramethyl pyrazine; therapeutic time window; thioredoxin reductase

Indexed keywords

MESSENGER RNA; NEUROPROTECTIVE AGENT; PYRAZINE DERIVATIVE; TETRAETHYLPYRAZINE; THIOREDOXIN 1; THIOREDOXIN 2; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG RESPONSE; GENE EXPRESSION; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; MALE; NEUROPROTECTIVE AGENTS; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; THIOREDOXIN REDUCTASE 1; THIOREDOXINS;

EID: 60449095358     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.11.004     Document Type: Article

References (22)

1. Li M., Handa S., Ikeda Y., and Goto S. Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong,' on platelet thrombus formation under high shear rates. Thromb Res 104 1 (Oct 1 2001) 15-28
2. Liao S.L., Kao T.K., Chen W.Y., Lin Y.S., Chen S.Y., Raung S.L., et al. Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci Lett 372 (2004) 40-45
3. Liu Q., Song J., and Chen S. Chinese medicine treatment of ischemic stroke research progress. Chin J Integr Tradit West Med 20 4 (2000) 309-312
4. Kasuno K., Nakamura H., Ono T., Muso E., and Yodoi J. Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia/reperfusion injury. Kidney Int 64 (2003) 1273-1282
5. Andoh T., Chock P.B., and Chiueh C.C. The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J Biol Chem 277 (2002) 9655-9660
6. Watson W.H., Yang X., Choi Y.E., Jones D.P., and Kehrer J.P. Thioredoxin and its role in toxicology. Toxicol Sci 78 (2004) 3-14
7. Powis G., and Montfort W.R. Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct 30 (2001) 421-455
8. Sabelli R., Iorio E., De Martino A., Ricci A., Viticchie G., Rotillio G., et al. Rhodanese-thioredoxin system and allyl sulfur compounds. FEBS J. 275 15 (Aug 2008) 3884-3899
9. Mustacich D., and Powis G. Thioredoxin reductase. Biochem J 346 1 (2000) 1-8
10. Yamada T., Iwasaki Y., Nagata K., Shinji Fushiki S., Nakamura H., Marunaka Y., et al. Thioredoxin-1 protects against hyperoxia-induced apoptosis in cells of the alveolar walls. Pulm Pharmacol Ther 20 (2007) 650-659
11. Hattori I., Takagi Y., Nakamura H., Nozaki K., Bai J., Kondo N., et al. Intravenous Administration of Thioredoxin Decreases Brain Damage Following Transient Focal Cerebral Ischemia in Mice. Antioxid Redox Signal 6 1 (Feb 2004) 81-87
12. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., and Moskowitz M. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 25 (1994) 1883-1885
13. Zea-longa E., Weinstein P.R., and Carlson S. Reversible middle cerebral artery occlusion without craniectomy in rat. Stroke 20 10 (1989) 84-91
14. Kao T.K., Ou Y.C., Kuo J.S., Chen W.Y., Liao S.L., Wu C.W., et al. Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats. Neurochem Int 48 (2006) 166-176
15. Jormalainen M., Vento A.E., Lukkarinen H., Kaapa P., Kyto V., Lauronen J., et al. Inhibition of thrombin during reperfusion improves immediate postischemic myocardial function and modulates apoptosis in a porcine model of cardiopulmonary bypass. J Cardiothorac Vasc Anesth 21 2 (Apr 2007) 224-231
16. Witt K.A., Slate C.A., Egleton R.D., Huber J.D., Yamamura H.I., Hruby V.J., and Davis T.P. Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin. J Neurochem 75 1 (2000) 424-435
17. Armstead W. NOC/oFQ activates PKC and generates superoxide to impair hypotensive cerebrovasodilation after hypoxia/ischemia. Med Sci Monit 8 1 (Jan 2002) BR8-BR14
18. Rhee S.G., Kang S.W., Chang T.S., Jeong W., and Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52 (2001) 35-41
19. Watson W.H., Yang X., Choi Y.E., Jones D.P., and Kehrer J.P. Thioredoxin and Its Role in Toxicology. Toxicol Sci 78 (2004) 3-14
20. Takagi Y., Tokime T., Nozaki K., Gon Y., Kikuchi H., and Yodoi J. Redox control of neuronal damage during brain ischemia after middle cerebral artery occlusion in the rat: immunohistochemical and hybridization studies of thioredoxin. J Cereb Blood Flow Metab 18 (1998) 206-214
21. Hori K., Katayama M., Sato N., Ishii K., Waga S., and Yodoi J. Neuroprotection by glial cells through adult T cell leukemiaderived factor/human thioredoxin (ADF/TRX). Brain Res 652 (1994) 304-310
22. Lee J.M., Grabb M.C., Zipfel G.J., and Choi D.W. Brain tissue responses to ischemia. J Clin Invest 106 (2000) 723-731